- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Comorbidities In Patients Living With Bipolar I Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Comorbidities In Patients Living With Bipolar I Disorder
Lifetime comorbidity rates in bipolar disorder are ~90%, and nearly half of these patients are treated for a minimum of three1. During this webinar, Otsuka Sr. MSL Dr. Michael Aldape will be talking with Dr. Joseph Goldberg who will guide us on a lively discussion addressing the complexities of psychiatric comorbidities associated with bipolar I disorder. This moderated session will explore common comorbidities, treatment options and the current guidelines for managing comorbid bipolar I patients.
1. Altinbas, K. Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder. Noro Psikiyatr Ars. 2021 Sep 20;58 (Suppl 1): S41-S46.

Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
More

Michael Aldape, PhD
Senior Medical Science Liaison
Speaker Joseph F Goldberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Michael Aldape, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)